ADIL MOHAMMED: Open Payments
NPI 1881929693 · LEESBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 19 payments from 14 companies in 2025. Trend: 2023 $1,015 · 2024 $472 · 2025 $392
Food & beverage: $392
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $61 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Lundbeck LLC | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $25 |
| Alkermes, Inc. | 1 | $22 |
| Corium, LLC | 1 | $20 |
| Bausch Health US, LLC | 1 | $20 |
Products named: Auvelity, AUSTEDO XR, CAPLYTA, REXULTI, INGREZZA, VRAYLAR, LYBALVI, Azstarys.
Industry payments across FL — which companies pay providers there.
